TLR4 and steatosis: To examine the effect of Tlr4 inhibition on hepatic NPC1L1‐mediated steatosis, we fed L1‐Tg mice a HFD containing IAXO101 (12 μg/g of feed), a commercially available synthetic antagonist of TLR4 signaling, for 2 weeks.